APO Research
Talk to an analyst

APO RESEARCH · REPORT

Apremilast Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Apremilast Tablets Market Analysis and Forecast 2026-2032

27 December 2025193 pages

Choose your research edition.

Industry ResearchApremilast Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Apremilast Tablets Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Apremilast Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apremilast Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Apremilast Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Apremilast Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Apremilast Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Apremilast Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Apremilast Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Apremilast Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Apremilast Tablets include CSPC Ouyi Pharmaceutical, Shanghai Modern Pharmaceutical, Qilu Pharmaceutical, Glenmark Pharmaceuticals and Amgen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Apremilast Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Apremilast Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Apremilast Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Apremilast Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Apremilast Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Apremilast Tablets sales, projected growth trends, production technology, application and end-user industry.

Apremilast Tablets Segment by Company

CSPC Ouyi Pharmaceutical

Shanghai Modern Pharmaceutical

Qilu Pharmaceutical

Glenmark Pharmaceuticals

Amgen

Apremilast Tablets Segment by Type

10mg/Tablet

20mg/Tablet

30mg/Tablet

Apremilast Tablets Segment by Application

Hospital Pharmacy

Retail Pharmacy

Apremilast Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apremilast Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apremilast Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apremilast Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Apremilast Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Apremilast Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apremilast Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Apremilast Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg/Tablet Major Manufacturers Table 3. 20mg/Tablet Major Manufacturers Table 4. 30mg/Tablet Major Manufacturers Table 5. Global Apremilast Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacy Major Manufacturers Table 7. Retail Pharmacy Major Manufacturers Table 8. Apremilast Tablets Industry Trends Table 9. Apremilast Tablets Industry Drivers Table 10. Apremilast Tablets Industry Opportunities and Challenges Table 11. Apremilast Tablets Industry Restraints Table 12. Global Apremilast Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Apremilast Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Apremilast Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Apremilast Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Apremilast Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Apremilast Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Apremilast Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Apremilast Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Apremilast Tablets Sales Market Share by Region (2021-2026) Table 21. Global Apremilast Tablets Sales Market Share by Region (2027-2032) Table 22. Global Apremilast Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Apremilast Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Apremilast Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Apremilast Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Apremilast Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Apremilast Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Apremilast Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Apremilast Tablets Manufacturers, Product Type & Application Table 30. Global Apremilast Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Apremilast Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Apremilast Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Apremilast Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Apremilast Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Apremilast Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Apremilast Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Apremilast Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Apremilast Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Apremilast Tablets Sales Market Share by Type (2021-2026) Table 42. Global Apremilast Tablets Sales Market Share by Type (2027-2032) Table 43. Global Apremilast Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Apremilast Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Apremilast Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Apremilast Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Apremilast Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Apremilast Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Apremilast Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Apremilast Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Apremilast Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Apremilast Tablets Sales Market Share by Application (2021-2026) Table 54. Global Apremilast Tablets Sales Market Share by Application (2027-2032) Table 55. Global Apremilast Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Apremilast Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. CSPC Ouyi Pharmaceutical Company Information Table 58. CSPC Ouyi Pharmaceutical Business Overview Table 59. CSPC Ouyi Pharmaceutical Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio Table 61. CSPC Ouyi Pharmaceutical Recent Development Table 62. Shanghai Modern Pharmaceutical Company Information Table 63. Shanghai Modern Pharmaceutical Business Overview Table 64. Shanghai Modern Pharmaceutical Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio Table 66. Shanghai Modern Pharmaceutical Recent Development Table 67. Qilu Pharmaceutical Company Information Table 68. Qilu Pharmaceutical Business Overview Table 69. Qilu Pharmaceutical Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Qilu Pharmaceutical Apremilast Tablets Product Portfolio Table 71. Qilu Pharmaceutical Recent Development Table 72. Glenmark Pharmaceuticals Company Information Table 73. Glenmark Pharmaceuticals Business Overview Table 74. Glenmark Pharmaceuticals Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio Table 76. Glenmark Pharmaceuticals Recent Development Table 77. Amgen Company Information Table 78. Amgen Business Overview Table 79. Amgen Apremilast Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Amgen Apremilast Tablets Product Portfolio Table 81. Amgen Recent Development Table 82. North America Apremilast Tablets Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Apremilast Tablets Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 85. North America Apremilast Tablets Sales by Type (2027-2032) & (K Units) Table 86. North America Apremilast Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 87. North America Apremilast Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 88. North America Apremilast Tablets Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Apremilast Tablets Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 91. North America Apremilast Tablets Sales by Application (2027-2032) & (K Units) Table 92. North America Apremilast Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 93. North America Apremilast Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 94. North America Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Apremilast Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Apremilast Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 98. North America Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 99. North America Apremilast Tablets Sales by Country (2027-2032) & (K Units) Table 100. North America Apremilast Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 101. North America Apremilast Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 102. United States Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 103. Canada Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 104. Mexico Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 105. Europe Apremilast Tablets Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Apremilast Tablets Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 108. Europe Apremilast Tablets Sales by Type (2027-2032) & (K Units) Table 109. Europe Apremilast Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 110. Europe Apremilast Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 111. Europe Apremilast Tablets Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Apremilast Tablets Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 114. Europe Apremilast Tablets Sales by Application (2027-2032) & (K Units) Table 115. Europe Apremilast Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 116. Europe Apremilast Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 117. Europe Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Apremilast Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Apremilast Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 121. Europe Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 122. Europe Apremilast Tablets Sales by Country (2027-2032) & (K Units) Table 123. Europe Apremilast Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 124. Europe Apremilast Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 125. Germany Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 126. France Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 127. U.K. Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 128. Italy Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 129. Russia Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 130. Spain Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 133. Sweden Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 134. Poland Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 135. China Apremilast Tablets Revenue by Type (2021-2026) & (US$ Million) Table 136. China Apremilast Tablets Revenue by Type (2027-2032) & (US$ Million) Table 137. China Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 138. China Apremilast Tablets Sales by Type (2027-2032) & (K Units) Table 139. China Apremilast Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Apremilast Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Apremilast Tablets Revenue by Application (2021-2026) & (US$ Million) Table 142. China Apremilast Tablets Revenue by Application (2027-2032) & (US$ Million) Table 143. China Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 144. China Apremilast Tablets Sales by Application (2027-2032) & (K Units) Table 145. China Apremilast Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Apremilast Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Apremilast Tablets Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Apremilast Tablets Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 150. Asia Apremilast Tablets Sales by Type (2027-2032) & (K Units) Table 151. Asia Apremilast Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Apremilast Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Apremilast Tablets Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Apremilast Tablets Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 156. Asia Apremilast Tablets Sales by Application (2027-2032) & (K Units) Table 157. Asia Apremilast Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Apremilast Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Apremilast Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Apremilast Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 164. Asia Apremilast Tablets Sales by Country (2027-2032) & (K Units) Table 165. Asia Apremilast Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Apremilast Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 168. South Korea Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 169. India Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 170. Australia Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Apremilast Tablets Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Apremilast Tablets Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Apremilast Tablets Sales by Type (2021-2026) & (K Units) Table 176. SAMEA Apremilast Tablets Sales by Type (2027-2032) & (K Units) Table 177. SAMEA Apremilast Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Apremilast Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Apremilast Tablets Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Apremilast Tablets Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Apremilast Tablets Sales by Application (2021-2026) & (K Units) Table 182. SAMEA Apremilast Tablets Sales by Application (2027-2032) & (K Units) Table 183. SAMEA Apremilast Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Apremilast Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Apremilast Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Apremilast Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 190. SAMEA Apremilast Tablets Sales by Country (2027-2032) & (K Units) Table 191. SAMEA Apremilast Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Apremilast Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 194. Argentina Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 195. Chile Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 196. Colombia Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 197. Peru Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 199. Israel Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 200. UAE Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 201. Turkey Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 202. Iran Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 203. Egypt Apremilast Tablets Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Apremilast Tablets Distributors List Table 207. Apremilast Tablets Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Apremilast Tablets Image Figure 2. Global Apremilast Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apremilast Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg/Tablet Image Figure 5. 20mg/Tablet Image Figure 6. 30mg/Tablet Image Figure 7. Global Apremilast Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Apremilast Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacy Image Figure 10. Retail Pharmacy Image Figure 11. Global Apremilast Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Apremilast Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Apremilast Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Apremilast Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Apremilast Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Apremilast Tablets Sales (2021-2032) & (K Units) Figure 17. Global Apremilast Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Apremilast Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Apremilast Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Apremilast Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Apremilast Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Apremilast Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Apremilast Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Apremilast Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Apremilast Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Apremilast Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Apremilast Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Apremilast Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Apremilast Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Apremilast Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Apremilast Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Apremilast Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Apremilast Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Apremilast Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Apremilast Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Apremilast Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Apremilast Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Apremilast Tablets Revenue Share by Type (2021-2032) Figure 40. North America Apremilast Tablets Sales Share by Type (2021-2032) Figure 41. North America Apremilast Tablets Revenue Share by Application (2021-2032) Figure 42. North America Apremilast Tablets Sales Share by Application (2021-2032) Figure 43. North America Apremilast Tablets Revenue Share by Country (2021-2032) Figure 44. North America Apremilast Tablets Sales Share by Country (2021-2032) Figure 45. Europe Apremilast Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Apremilast Tablets Sales Share by Type (2021-2032) Figure 47. Europe Apremilast Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Apremilast Tablets Sales Share by Application (2021-2032) Figure 49. Europe Apremilast Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Apremilast Tablets Sales Share by Country (2021-2032) Figure 51. China Apremilast Tablets Revenue Share by Type (2021-2032) Figure 52. China Apremilast Tablets Sales Share by Type (2021-2032) Figure 53. China Apremilast Tablets Revenue Share by Application (2021-2032) Figure 54. China Apremilast Tablets Sales Share by Application (2021-2032) Figure 55. Asia Apremilast Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Apremilast Tablets Sales Share by Type (2021-2032) Figure 57. Asia Apremilast Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Apremilast Tablets Sales Share by Application (2021-2032) Figure 59. Asia Apremilast Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Apremilast Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Apremilast Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Apremilast Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Apremilast Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Apremilast Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Apremilast Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Apremilast Tablets Sales Share by Country (2021-2032) Figure 67. Apremilast Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Apremilast Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/Tablet
  • 20mg/Tablet
  • 30mg/Tablet
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • CSPC Ouyi Pharmaceutical
  • Shanghai Modern Pharmaceutical
  • Qilu Pharmaceutical
  • Glenmark Pharmaceuticals
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Apremilast Tablets Market by Type
  3. 1.2.1 Global Apremilast Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg/Tablet
  5. 1.2.3 20mg/Tablet
  6. 1.2.4 30mg/Tablet
  7. 1.3 Apremilast Tablets Market by Application
  8. 1.3.1 Global Apremilast Tablets Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacy
  10. 1.3.3 Retail Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Apremilast Tablets Market Dynamics
  1. 2.1 Apremilast Tablets Industry Trends
  2. 2.2 Apremilast Tablets Industry Drivers
  3. 2.3 Apremilast Tablets Industry Opportunities and Challenges
  4. 2.4 Apremilast Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Apremilast Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Apremilast Tablets Revenue by Region
  3. 3.2.1 Global Apremilast Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Apremilast Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Apremilast Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Apremilast Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Apremilast Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Apremilast Tablets Sales by Region
  9. 3.4.1 Global Apremilast Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Apremilast Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Apremilast Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Apremilast Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Apremilast Tablets Revenue by Manufacturers
  2. 4.1.1 Global Apremilast Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Apremilast Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Apremilast Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Apremilast Tablets Sales by Manufacturers
  6. 4.2.1 Global Apremilast Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Apremilast Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Apremilast Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Apremilast Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Apremilast Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Apremilast Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Apremilast Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Apremilast Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Apremilast Tablets Market CR5 and HHI
  16. 4.8.2 2025 Apremilast Tablets Tier 1, Tier 2, and Tier 3
5 Apremilast Tablets Market by Type
  1. 5.1 Global Apremilast Tablets Revenue by Type
  2. 5.1.1 Global Apremilast Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Apremilast Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Apremilast Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Apremilast Tablets Sales by Type
  6. 5.2.1 Global Apremilast Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Apremilast Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Apremilast Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Apremilast Tablets Price by Type
6 Apremilast Tablets Market by Application
  1. 6.1 Global Apremilast Tablets Revenue by Application
  2. 6.1.1 Global Apremilast Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Apremilast Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Apremilast Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Apremilast Tablets Sales by Application
  6. 6.2.1 Global Apremilast Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Apremilast Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Apremilast Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Apremilast Tablets Price by Application
7 Company Profiles
  1. 7.1 CSPC Ouyi Pharmaceutical
  2. 7.1.1 CSPC Ouyi Pharmaceutical Company Information
  3. 7.1.2 CSPC Ouyi Pharmaceutical Business Overview
  4. 7.1.3 CSPC Ouyi Pharmaceutical Apremilast Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio
  6. 7.1.5 CSPC Ouyi Pharmaceutical Recent Developments
  7. 7.2 Shanghai Modern Pharmaceutical
  8. 7.2.1 Shanghai Modern Pharmaceutical Company Information
  9. 7.2.2 Shanghai Modern Pharmaceutical Business Overview
  10. 7.2.3 Shanghai Modern Pharmaceutical Apremilast Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio
  12. 7.2.5 Shanghai Modern Pharmaceutical Recent Developments
  13. 7.3 Qilu Pharmaceutical
  14. 7.3.1 Qilu Pharmaceutical Company Information
  15. 7.3.2 Qilu Pharmaceutical Business Overview
  16. 7.3.3 Qilu Pharmaceutical Apremilast Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharmaceutical Apremilast Tablets Product Portfolio
  18. 7.3.5 Qilu Pharmaceutical Recent Developments
  19. 7.4 Glenmark Pharmaceuticals
  20. 7.4.1 Glenmark Pharmaceuticals Company Information
  21. 7.4.2 Glenmark Pharmaceuticals Business Overview
  22. 7.4.3 Glenmark Pharmaceuticals Apremilast Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio
  24. 7.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 7.5 Amgen
  26. 7.5.1 Amgen Company Information
  27. 7.5.2 Amgen Business Overview
  28. 7.5.3 Amgen Apremilast Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Amgen Apremilast Tablets Product Portfolio
  30. 7.5.5 Amgen Recent Developments
8 North America
  1. 8.1 North America Apremilast Tablets Market Size by Type
  2. 8.1.1 North America Apremilast Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Apremilast Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Apremilast Tablets Price by Type (2021-2032)
  5. 8.2 North America Apremilast Tablets Market Size by Application
  6. 8.2.1 North America Apremilast Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Apremilast Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Apremilast Tablets Price by Application (2021-2032)
  9. 8.3 North America Apremilast Tablets Market Size by Country
  10. 8.3.1 North America Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Apremilast Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Apremilast Tablets Market Size by Type
  2. 9.1.1 Europe Apremilast Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Apremilast Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Apremilast Tablets Price by Type (2021-2032)
  5. 9.2 Europe Apremilast Tablets Market Size by Application
  6. 9.2.1 Europe Apremilast Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Apremilast Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Apremilast Tablets Price by Application (2021-2032)
  9. 9.3 Europe Apremilast Tablets Market Size by Country
  10. 9.3.1 Europe Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Apremilast Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Apremilast Tablets Market Size by Type
  2. 10.1.1 China Apremilast Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Apremilast Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Apremilast Tablets Price by Type (2021-2032)
  5. 10.2 China Apremilast Tablets Market Size by Application
  6. 10.2.1 China Apremilast Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Apremilast Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Apremilast Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Apremilast Tablets Market Size by Type
  2. 11.1.1 Asia Apremilast Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Apremilast Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Apremilast Tablets Price by Type (2021-2032)
  5. 11.2 Asia Apremilast Tablets Market Size by Application
  6. 11.2.1 Asia Apremilast Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Apremilast Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Apremilast Tablets Price by Application (2021-2032)
  9. 11.3 Asia Apremilast Tablets Market Size by Country
  10. 11.3.1 Asia Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Apremilast Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Apremilast Tablets Market Size by Type
  2. 12.1.1 SAMEA Apremilast Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Apremilast Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Apremilast Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Apremilast Tablets Market Size by Application
  6. 12.2.1 SAMEA Apremilast Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Apremilast Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Apremilast Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Apremilast Tablets Market Size by Country
  10. 12.3.1 SAMEA Apremilast Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Apremilast Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Apremilast Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Apremilast Tablets Value Chain Analysis
  2. 13.1.1 Apremilast Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Apremilast Tablets Production Mode & Process
  6. 13.2 Apremilast Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Apremilast Tablets Distributors
  9. 13.2.3 Apremilast Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst